| Literature DB >> 29071478 |
Sayaka Kamijima1, Akiko Sekiya1, Mao Takata2, Haruka Nakano1, Morika Murakami1, Tomonori Nakazato3, Hidesaku Asakura4, Eriko Morishita5,6.
Abstract
Inherited antithrombin (AT) deficiency is one of the most clinically significant forms of congenital thrombophilia and follows an autosomal dominant mode of inheritance. We analyzed SERPINC1 in a patient who developed deep-vein thrombosis and low AT activity during pregnancy, and identified a novel missense mutation c.259A>G (p.Asn87Asp; N87D). Surprisingly, analysis of the parents' DNA showed that they did not possess this mutant, and thus, it may have been due to a de novo mutation. We also expressed this mutant AT protein in COS-1 cells and compared its intracellular localization and intracellular and extracellular antigen levels with that of wild-type AT. The expression experiment did not reveal a significant difference in the antigen levels of the mutant and wild-type AT in the cell lysate, but the mutant AT antigen level was markedly lower than that of its wild-type counterpart in the COS-1 cell supernatant. Immunofluorescence did not indicate any difference between the mutant and wild-type AT in terms of cytoplasmic localization of fluorescence signals. Our findings suggest that the patient's AT deficiency may have been caused by impaired extracellular secretion of mutant AT protein p.Asn87Asp.Entities:
Keywords: Antithrombin deficiency; De novo mutation; Functional analysis; Missense mutation; Venous thrombosis
Mesh:
Substances:
Year: 2017 PMID: 29071478 DOI: 10.1007/s12185-017-2352-8
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490